创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: Characteristics and Application Prospects of PBMC Mixed Inoculation Models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-05 15:29
  • Views:

(Summary description)In biomedical research, human peripheral blood mononuclear cell (PBMC) models are widely used to simulate human immune responses and disease processes. As an advanced experimental tool, the PBMC hybrid inoculation model of InnoModels Biotechnology has attracted wide attention in the field of immunology research with its unique advantages. In this paper, we will introduce the features of the model of hybrid inoculation of InnoModels Biotechnology PBMC and discuss the prospects of its application

InnoModels: Characteristics and Application Prospects of PBMC Mixed Inoculation Models

(Summary description)In biomedical research, human peripheral blood mononuclear cell (PBMC) models are widely used to simulate human immune responses and disease processes. As an advanced experimental tool, the PBMC hybrid inoculation model of InnoModels Biotechnology has attracted wide attention in the field of immunology research with its unique advantages. In this paper, we will introduce the features of the model of hybrid inoculation of InnoModels Biotechnology PBMC and discuss the prospects of its application

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-05 15:29
  • Views:
Information

In biomedical research, human peripheral blood mononuclear cell (PBMC) models are widely used to simulate human immune responses and disease processes. As an advanced experimental tool, the PBMC hybrid inoculation model of InnoModels Biotechnology has attracted wide attention in the field of immunology research with its unique advantages. In this paper, we will introduce the features of the model of hybrid inoculation of InnoModels Biotechnology PBMC and discuss the prospects of its application.
Model features:
1. Highly simulate the human body environment: By simulating the cellular environment in the human body, the PBMC hybrid inoculation model of InnoModels Biotechnology is able to more realistically reflect the immune response of the human body after pathogen infection or vaccination. This model not only contains a variety of immune cells, but also simulates cell-cell interactions and signaling, thus providing a research platform that is closer to the actual human body.
2. High flexibility: The model can be flexibly adjusted according to the research needs in terms of the types of pathogens to be inoculated, their concentrations and the time of inoculation, in order to more accurately simulate different infection scenarios or immunization protocols. Meanwhile, the model is relatively simple to construct and can be personalized according to laboratory conditions and needs.
3. Highly reproducible: The InnoModels PBMC hybrid inoculation model has a high degree of standardization in operation and high reproducibility of experimental results. This provides researchers with a stable and reliable research tool, which helps to promote the progress of immunology and biomedical fields.
4. Wide range of adaptation: The model is not only suitable for studying the immune mechanism of infectious diseases, but also can be used in many fields such as vaccine development, drug screening and immunotherapy. By adjusting the vaccination conditions and observation indexes, the immune response process under different disease states can be studied in depth.

 


Application Prospects:
As an advanced biomedical research tool, the PBMC hybrid inoculation model has a broad application prospect. With the continuous development of immunology and biomedicine, the model will play an important role in the following aspects:
1. vaccine development: by simulating the immune response after vaccination, the effectiveness and safety of vaccines can be evaluated, providing strong support for the development of new vaccines.
2. drug screening: using the model, drug candidates with immunomodulatory or anti-infective effects can be screened to provide experimental basis for clinical drug development.
3. immunotherapy research: by intervening the immune cells in the model, the effect and mechanism of different immunotherapy strategies can be studied, providing theoretical support for clinical immunotherapy.
4. Disease mechanism research: By simulating the immune response under different disease states, we can gain a deeper understanding of the pathogenesis and pathological process of diseases, and provide new ideas and methods for disease prevention and treatment.
In summary, with its highly simulated human environment, high flexibility, repeatability and wide range of adaptability, InnoModels Biotechnology PBMC hybrid inoculation model shows great potential and value in the field of biomedical research. With the continuous progress of science and technology and the improvement of experimental methods, the model will play a more important role in promoting the development of immunology and biomedical fields.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司